One Hundred Thousand Procedure Milestone Achieved by Stereotaxis’ Robotic Technology
“Surpassing 100,000 patients treated is an impressive milestone. It is a testament to the significant clinical value that our technology provides patients and physicians in the electrophysiology field. It also is a reminder of the robust validation of our technology.
Stereotaxis’ robotic technology is being utilized by hundreds of physicians at over one hundred hospitals across 30 countries globally. Its clinical value has been documented in nearly 300 peer reviewed publications.
This press release includes statements that may constitute "forward-looking" statements, usually containing the words "believe”, "estimate”, "project”, "expect" or similar expressions. Forward-looking statements inherently involve risks and uncertainties that could cause actual results to differ materially from the forward-looking statements. Factors that would cause or contribute to such differences include, but are not limited to, the Company's ability to raise additional capital on a timely basis and on terms that are acceptable, its ability to continue to manage expenses and cash burn rate at sustainable levels, its ability to continue to work with lenders to extend, repay or refinance indebtedness, or to obtain additional financing, in either case on acceptable terms, continued acceptance of the Company's products in the marketplace, the effect of global economic conditions on the ability and willingness of customers to purchase its systems and the timing of such purchases, competitive factors, changes resulting from healthcare reform in
David L. FischelChairman and Acting Chief Executive Officer Martin C. StammerChief Financial Officer 314-678-6100 firstname.lastname@example.org